在中枢神经系统受伤时,TrkB/BDNF信号通路及其小分子激动剂在中枢神经系统受伤
Yujin Wang1, Jing Liang2, Boyu Xu1
1Division of Spine, Department of Orthopedics, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China; Key Laboratory of Spine and Spinal cord Injury Repair and Regeneration (Tongji University), Ministry of Education, Shanghai 200072, China; Medical School, Tongji University, Shanghai 200433, China.
Life sciences
|November 26, 2023
概括
大脑衍生神经营养因子 (BDNF) 和它的受体TrkB对于中枢神经系统 (CNS) 的健康和修复至关重要. 本综述探讨了中枢神经系统损伤中的BDNF/TrkB信号传递和潜在的治疗激动剂.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 脑衍生神经营养因子 (BDNF) 是中枢神经系统 (CNS) 中的一个关键神经营养因子.
- BDNF通过与其受体结合而发挥其功能,即与托罗普米奥辛相关的激酶受体B (TrkB).
- BDNF/TrkB通路对于神经元的生存,结构性可塑性和突触调节至关重要.
研究的目的:
- 审查中枢神经系统损伤中BDNF/TrkB信号通路的表达模式和机制.
- 为治疗开发引入新的小分子TrkB受体激动剂.
主要方法:
- 对中枢神经系统损伤中BDNF/TrkB信号传递研究的文献综述.
- 对小分子TrkB激动剂的研究分析.
主要成果:
- 在中枢神经系统受伤后,BDNF/TrkB途径对神经元的生存和可塑性至关重要.
- BDNF/TrkB信号的失调与神经退行性和神经创伤性疾病有关.
- 已经开发了几种小分子TrkB激动剂,显示出治疗潜力.
结论:
- 了解BDNF/TrkB机制为神经精神疾病提供了新的治疗策略.
- 小分子TrkB激动剂代表了治疗中枢神经系统损伤和神经退行性疾病的有希望的途径.
相关概念视频
Enzyme-linked Receptors
78.5K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.5K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K


